Evaluation of safety, effectiveness and treatment patterns of sodium zirconium cyclosilicate in management of hyperkalaemia in China: a real-world study protocol

Evaluation of safety, effectiveness and treatment patterns of sodium zirconium cyclosilicate in management of hyperkalaemia in China: a real-world study protocol

Introduction Hyperkalaemia (HK) is a potentially life-threatening electrolyte imbalance associated with several adverse clinical outcomes. The efficacy and negative effects of currently existing treatment options have made HK management questionable. Sodium zirconium cyclosilicate (SZC), a novel hig...

Full description

Bibliographic Details
Main Authors:	Jing Yang, Lu Li, Nan Shen, Qing Li, Huimin Wang, Hongli Lin, Jianmin Wang, LI Zuo, Xun Luo, Niansong Wang, Hua Xie, Xinyu Liu, Zhenwei Shi, Yao Hu, Yifan Wu, Gang Long, Chunyan Liu, Lihong Zhang, Xin Wan, Qingyang Meng, Jianrong Zhao, Changying Xing, Qiang Zhu, Chunyan Shan, Xudong Cai, Jianming Ye, Shaojiang Tian, Yongqiang Lin, Xiaoyong Yu, Jingwei Zhou, Yanping Cao, Xinxin Jiang, Henglan Wu, Zhaohua Wang, Jingdong He, Juan Cao, Fenglei Wu, Cong Ma, Xun Yin, Zhongxin Li
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-03-01
Series:	BMJ Open
Online Access:	https://bmjopen.bmj.com/content/13/3/e070530.full

Similar Items

Effectiveness, safety, and treatment pattern of sodium zirconium cyclosilicate in Chinese patients with hyperkalemia: interim analysis from a multicenter, prospective, real-world study (Actualize Study)
by: Nan Shen, et al.
Published: (2024-07-01)

Corrigendum: Effectiveness, safety, and treatment pattern of sodium zirconium cyclosilicate in Chinese patients with hyperkalemia: interim analysis from a multicenter, prospective, real-world study (Actualize Study)
by: Nan Shen, et al.
Published: (2024-10-01)

Evaluation of the effect of sodium zirconium cyclosilicate on arrhythmia-related cardiovascular outcomes in patients receiving chronic haemodialysis with hyperkalaemia: protocol for the multicentre, randomised, controlled DIALIZE-Outcomes study
by: Michel Jadoul, et al.
Published: (2023-05-01)

Potassium reduction with sodium zirconium cyclosilicate in patients with heart failure
by: Jean‐Claude Tardif, et al.
Published: (2023-04-01)

Cost-effectiveness analysis of sodium zirconium cyclosilicate for treating hyperkalemia among Chinese patients
by: Lei Tian, et al.
Published: (2023-12-01)

Effects of Patiromer and Sodium Zirconium Cyclosilicate on Blood Pressure in Rats with Chronic Kidney Disease
by: Lingyun Li MD, PhD, et al.
Published: (2024-02-01)

In-vitro study of lithium binding by sodium zirconium cyclosilicate (Lokelma®) or patiromer (Veltassa®)
by: David B. Liss, et al.
Published: (2021-11-01)

Sodium zirconium cyclosilicate pretreatment for formula in vitro reduces potassium intake in infants with chronic kidney disease
by: Boxuan Liu, et al.
Published: (2022-12-01)

Unconventional route of administration of sodium zirconium cyclosilicate via nasogastric tube: A case report
by: Miriam Barrales Iglesias, et al.
Published: (2024-05-01)

Sodium zirconium cyclosilicate hydrate reduces medical expenses compared with hemodialysis in patients with acute hyperkalemia
by: Hayato Fujioka, et al.
Published: (2023-11-01)

Radiopacity of Sodium Zirconium Cyclosilicate in Computed Tomography: a case of a patient with Hyperkalemia and kidney disease
by: Andrea Angioi, et al.
Published: (2023-12-01)

Successful Conversion from Conventional Potassium Binder to Sodium Zirconium Cyclosilicate in a Patient with Refractory Constipation
by: Teruhiko Imamura, et al.
Published: (2022-05-01)

Medical Costs in Patients with Hyperkalemia on Long-Term Sodium Zirconium Cyclosilicate Therapy: The RECOGNIZE II Study
by: Agiro A, et al.
Published: (2023-09-01)

Compared effectiveness of sodium zirconium cyclosilicate and calcium polystyrene sulfonate on hyperkalemia in patients with chronic kidney disease
by: Takashin Nakayama, et al.
Published: (2023-03-01)

Cost-effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalemia in patients with chronic kidney disease or heart failure in Spain
by: Roberto Alcázar-Arroyo, et al.
Published: (2024-09-01)

Potassium homeostasis and therapeutic intervention with sodium zirconium cyclosilicate: A model‐informed drug development case study
by: Lindsay E. Clegg, et al.
Published: (2024-02-01)

Sodium zirconium cyclosilicate (ZS-9) treatment in patients with serum potassium >6.5 mEq/L
by: Henrik Rasmussen
Published: (2015-09-01)

Advancing crush syndrome management: the potent role of Sodium zirconium cyclosilicate in early hyperkalemia intervention and survival enhancement in a rat model
by: Duo Li, et al.
Published: (2024-05-01)

Hyperkalaemia in Heart Failure
by: Umar Ismail, et al.
Published: (2021-05-01)

Sodium Zirconium Cyclosilicate for Renin–Angiotensin–Aldosterone System Inhibitor Optimization in Patients with Heart Failure with Reduced Ejection Fraction: A Retrospective Analysis
by: Rhys Williams, et al.
Published: (2024-11-01)

Consensus document on the management of hyperkalaemia. Response
by: Antoni Lorente
Published: (2023-11-01)

Prevalence and factors associated with false hyperkalaemia in Asians in primary care: a cross-sectional study (the Unlysed Hyperkalaemia- the Unseen Burden (UHUB) study)
by: Ngiap Chuan Tan, et al.
Published: (2020-09-01)

Captopril: reversible renal failure with severe hyperkalaemia.
by: Grossman, A, et al.
Published: (1980)

Epidemiology and risk factors for hyperkalaemia in heart failure
by: Diederick E. Grobbee, et al.
Published: (2024-08-01)

Electrocardiographic changes associated with hyperkalaemia in domestic cats
by: S. P. Bakshi, et al.
Published: (2023-03-01)

Letters: The first symptom of hyperkalaemia is death (multiple letters)
by: Grossman, C, et al.
Published: (2004)

Reducing the harm associated in treating hyperkalaemia with insulin and dextrose
by: Sara Abou Sherif, et al.
Published: (2024-07-01)

Impact of treatment of hyperkalaemia on quality of life: design of a prospective observational cohort study of long-term management of hyperkalaemia in patients with chronic kidney disease or chronic heart failure in Japan
by: Ken-ei Sada, et al.
Published: (2023-12-01)

The ventilatory response to lowering potassium with dextrose and insulin in subjects with hyperkalaemia.
by: Paterson, D, et al.
Published: (1989)

Hypoglycaemia and monitoring practices following insulin-dextrose therapy for hyperkalaemia
by: Samuel Ford, et al.
Published: (2025-03-01)

Observational study of the relative efficacy of insulin-glucose treatment for hyperkalaemia in patients with liver cirrhosis
by: Jeanette H Pham, et al.
Published: (2021-10-01)

Hyperkalaemia as a cause of undertreatment with mineralocorticoid receptor antagonists in heart failure
by: Josefin Henrysson, et al.
Published: (2023-02-01)

Multicentre, observational, retrospective cohort of hyperkalaemia burden at haemodialysis facility-level in China: the Visualize-HD study protocol
by: LI Zuo, et al.
Published: (2023-09-01)

Cardiac sympathetic nerve stimulation enhances cardiovascular performance during hyperkalaemia in the anaesthetized pig.
by: O'Neill, M, et al.
Published: (1993)

Hyperkalaemia among hospital admissions: prevalence, risk factors, treatment and impact on length of stay
by: Yalin Yu, et al.
Published: (2024-12-01)

Hypoglycaemia due to insulin therapy for the management of hyperkalaemia in hospitalised adults: A scoping review.
by: Mogamat-Yazied Chothia, et al.
Published: (2022-01-01)

Characterisation of the Cullin‐3 mutation that causes a severe form of familial hypertension and hyperkalaemia
by: Frances‐Rose Schumacher, et al.
Published: (2015-08-01)

Experience with the potassium binder patiromer in hyperkalaemia management in heart failure patients in real life
by: Alberto Esteban‐Fernández, et al.
Published: (2022-10-01)

Non-inferiority of sodium zirconium cyclosilicate versus potassium-restricted diet in achieving normokalaemia in patients with type 2 diabetes mellitus: protocol for a multicentre, open-label, randomised controlled, two-arm clinical trial (SILVERSTAR study)
by: Masahiro Yamazaki, et al.
Published: (2025-03-01)

Hyperkalaemia prevalence, recurrence and treatment in patients on haemodialysis in China: protocol for a prospective multicentre cohort study (PRECEDE-K)
by: Li Yao, et al.
Published: (2021-12-01)